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1.	  To	  what	  extent	  are	  missing	  data	  reported	  in	  
accordance	  with	  current	  reporting	  guidance?	  	  
	  
2.	  Does	  the	  quality	  of	  reporting	  diﬀer	  between	  missing	  
data	  reporting	  criteria	  speciﬁed	  by	  CONSORT	  vs.	  those	  
not	  speciﬁed	  by	  CONSORT?	  
	  
3.	  Are	  journal	  impact	  factor	  and	  CONSORT	  endorsement	  
status	  associated	  with	  the	  quality	  of	  missing	  data	  
reporting?	  
¡  P=	  advanced	  life-­‐limiting	  disease	  
¡  I	  =	  palliative	  
¡  C=	  palliative	  /	  usual	  care	  /	  placebo	  
¡  O	  =	  Patient	  reported	  /	  dependent	  
¡  S	  =	  RCTs	  
	  
¡  Information	  specialist	  searched:	  CENTRAL,	  
OVID	  Medline,	  EMBASE	  (Jan	  2009-­‐April	  2014)	  
¡  Random	  selection	  /	  no	  language	  restrictions	  /	  
double	  screening,	  selection,	  extraction	  
	  
1.  Proportion	  of	  missing	  data	  
2.  Reasons	  for	  missing	  data	  
3.  Minimising	  missing	  data	  
4.  Risk	  of	  bias	  posed	  by	  missing	  data	  
5.  Justiﬁcation	  of	  missing	  data	  analytical	  
approach	  
6.  Statistical	  methods	  to	  handle	  missing	  data	  
7.  Impact	  of	  missing	  data	  on	  trial	  ﬁndings	  
	  	  	  
Reasons	  for	  exclusion:	  
Participant	  =	  13	  
Intervention	  =	  4	  
Outcome	  =	  17	  
Study	  design	  =	  15	  
Duplicate	  data	  =	  12	  
Other	  =	  10	  
Records	  identiﬁed	  through	  
database	  searching	  
N=1936	  
Additional	  records	  identiﬁed	  
through	  other	  sources	  
N=0	  
Numbers	  after	  duplicates	  
removed	  
N	  =	  1923	  
Records	  excluded	  
N	  =	  1745	  
Full-­‐text	  articles	  assessed	  
for	  eligibility	  
N	  =	  179	  
Studies	  included	  in	  
synthesis	  
N	  =	  108	  
Full-­‐text	  articles	  excluded	  
N	  =	  71	  
Search:	  PRISMA	  Flow	  diagram	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Missing	  data	  reporting	  criterion	  	   Proportion	  of	  trials	  reporting	  
the	  criterion	  
Account for all participants who enter the study	   69% (75/108)	  
Report number of participants not included in the 
primary outcome analysis	   94% (101/108)	   	  
Report number of participants with missing data in 
each arm in the primary outcome analysis (non-
crossover trials)	   87% (85/98) 	   	  
Report amount of item-level missing data in the 
primary outcome analysis (if primary outcome was a 
scale summary)	   10% (5/50)	   	  
Report missing data trend over time for primary 
outcomes measured repeatedly	   All time points: 7% (5/69)	  Some time-points: 48% (33/69)	  
Report amount of missing data for secondary 
outcomes if measured	   For all: 9% (9/99)	  For some: 18% (18/99)	  
Missing data reporting criterion	   Proportion of trials 
reporting the criterion	  
Report reason for missing data	   71% (66/931)	  
Report amount of missing data due to 
death	   65% (60/93)	  
Report amount of missing data due to 
illness/disease progression	   46% (43/93)	  
1	  Fifteen	  trials	  reported	  no	  missing	  data	  
For	  53%	  of	  participants	  with	  missing	  data	  the	  reason	  was	  described	  as	  
	  ‘LTFU’	  or	  ‘withdrawal’	  only	  
Missing data reporting criterion	   Proportion of trials 
reporting the criterion	  
Report plans to minimise missing data 	   27% (29/108)	  
Report comparison of baseline 
characteristics of those with observed 
data	   6% (6/93)	  
Report comparison of baseline 
characteristics of those with missing 
data	   0%	  
Missing data reporting criterion	   Proportion of trials 
reporting the criterion	  
Report assumed mechanism of missing 
data	   3% (3/108)	  
Report criteria for missing not at 
random (informative missing data)	   1% (1/108)	  
Report pattern of missingness	   0%	  
Compare baseline characteristics of 
those with and without missing data	   13% (12/93)	  
Missing data reporting criterion	   Proportion of trials 
reporting the criterion	  
Report methods used to handle missing 
data	   48% (45/93)	  
Report missing data sensitivity analyses 	   16% (15/93)	  
Report any changes to the planned 
missing data analysis	   0%	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¡  46%	  (43/93)	  
¡  Limitations	  section	  
¡  13	  discussed	  potential	  for	  missing	  data	  to	  bias	  
the	  treatment	  eﬀect	  estimate	  
	  
0%	   10%	   20%	   30%	   40%	   50%	   60%	   70%	   80%	   90%	   100%	  
MD	  due	  to	  death	  
Methods	  to	  handle	  MD	  	  
Impact	  
MD	  due	  to	  illness	  
Minimising	  
MD	  sensitivity	  analysis	  
Compare	  observed:missing	  
Item-­‐level	  MD	  
Secondary	  outcomes	  MD	  
Repeated	  measures	  MD	  
Risk	  of	  bias	  
Assumed	  mechanism	  
MNAR	  criteria	  
Changes	  to	  analysis	  
Pattern	  
Non-­‐CONSORT	  
No.	  of	  participants	  missing	  
MD	  in	  each	  arm	  
Reason	  for	  MD	  
Account	  for	  all	  participants	  
CONSORT	  
Journal impact factor 





doubling	  	  	  	  
95%	  CI	   Odds	  
ratio	  
95%	  CI	  
Account for all 
participants* 	   1.54	   1.20, 1.97	   2.46	   0.73, 8.23	  
No. of participants not 
included in the primary 
outcome analysis*	   1.39	   1.15, 1.69	   1.20	   0.31, 4.70	  
Reasons for MD*	   0.88	   0.63, 1.23	   0.65	   0.20, 2.17	  
Plans to minimise MD	   1.16	   0.94, 1.42	   1.00	   0.40, 2.49	  
Compare baseline 
characteristics of those 
with and without MD	   1.50	   1.20, 1.87	   1.11	   0.42, 2.92	  
Methods to handle MD	   1.40	   1.13, 1.73	   2.53	   1.08, 5.94	  
MD sensitivity analyses 	   1.20	   0.81, 1.80	   3.48	   1.15, 10.50	  
Impact on findings	   1.14	   0.93, 1.41	   1.85	   0.85, 4.04	  
¡  Q1.	  The	  reporting	  of	  missing	  data	  in	  palliative	  care	  trials	  
does	  not	  comply	  fully	  with	  current	  reporting	  guidance	  
	  
¡  Q2.	  Criteria	  speciﬁed	  by	  CONSORT	  were	  better	  reported	  
¡  Q3.	  The	  odds	  of	  reporting	  the	  majority	  of	  the	  MD	  criteria	  
increased	  as	  journal	  impact	  factor	  increased	  and	  in	  




1. Report the justification of the missing data analytical approach including all of the following: 
a. Any assumptions about the missing data mechanism1 with justification. 
b. What analyses will be performed to support assumptions about the missingness mechanism. For example, comparison of variables according to whether the 
partially observed variable of interest was missing may shed light on the credibility of the MAR assumption.  
c. *How the assumed missingness mechanism and any relevant features of the data such as pattern of missingness would influence the choice of method(s) to 
handle missing data and missing data sensitivity analyses. 
d. Details of the statistical methods used to handle missing data. 
e. How truncated data due to death will be handled and justification of method(s) (if applicable)2. 
 
Results section: 
2. Report the following measures of amount of missing data: 
a. For each outcome: number of participants in each arm with missing data (unit-level missing data).  
b. For outcomes that are scale summaries: amount of item-level missing data, for example the number of participants in each arm with some items reported and 
some items missing, and/or the proportion of item-level missing data. 
c. For repeated outcomes: number of participants in each arm with missing data at each time-point. 
3. Reasons for missing data in each arm, with enough detail that the reported reason can be used to reduce the uncertainty about the potential underlying mechanism 
of missing data- although this will not be verifiable using the partially observed data. If terms such as lost to follow up or withdrawal are used, these must be 
defined. 
 4. Comparison of the baseline characteristics of those included in the analysis (if participants are excluded from the analysis post-randomisation). 
 5. *Results of investigations of the missingness mechanism and/or pattern, and whether these led to changes to the choice of the primary method3  to handle 
missing data. 
 6. *Missing data sensitivity analyses results including analyses based on plausible missing not at random assumptions if appropriate. 
  
Discussion section: 
7. Impact of missing data on the interpretation of findings, including effect on validity and generalisability. 
  
